China Monoclonal Antibody (Mcab) Market Share, Size, Trends, Growth, Research and Development Trend Forecast 2014-2018

Hexa Reports

Market Research Reports and Insightful Company Profiles

China Monoclonal Antibody (McAB) Market Share, Size,

Trends, Growth, Research and Development Trend Forecast

2014-2018

Research on China Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth analysis on

policy environment, global market, Chinese market, as well as the latest developments of domestic key

enterprises related to China's monoclonal antibody industry.

Several Chinese large-scale pharmaceutical enterprises devoted themselves to research and

development of monoclonal antibody agents, which have achieved results in 2013. Hengrui Medicine

Co., Ltd., Shanghai Pharmaceuticals Co., Ltd. and Qilu Pharm have applied for clinical research of

monoclonal antibody agents. And Walvax Biotechnology Co., Ltd even made a huge investment in

purchasing Genor Biopharma Co., Ltd, attempting to establish a large biological strategy.

Browse Detail Report With TOC @

http://hexareports.com/report/research-on-china-monoclonal-antibody-mcab-industry-2014/details

Although large-scale pharmaceutical enterprises entered monoclonal antibody field on a large scale, the

overall innovation is still insufficient, and the market is represented by monoclonal antibody agents and

biological analogue that have submitted applications, few imitated drugs, and innovative medicines are

rare and precious things, mainly on account of high risks and long-time cycle.

Hexa Reports

Market Research Reports and Insightful Company Profiles

Due to late state, China's strength on research and development will be still vulnerable within future

three to five years, so it has to open the market preliminarily by depending on generic drugs. In 2013,

the market size was CNY 3.8 billion around, up 30% year-on-year; product categories and sales volume

were far less than that of European and American countries.

According to statistical data of Shanghai Pharmaceutical Profession Association (SPPA), China will see

four to six...